Philippe Pibarot

Clinical researcher
Quebec Heart and Lung Institute - Quebec, Canada

Latest contributions

Potential pitfalls of TAVI in low-risk patients

19 May 2017 – From EuroPCR 2017

Choosing the optimal access site for TAVI

18 May 2017 – From EuroPCR 2017

An image is worth 1,000 words

18 May 2017 – From EuroPCR 2017

Valve-in-valve TAVI for the failing bioprosthesis

17 May 2017 – From EuroPCR 2017

Mitral regurgitation: what the interventionist needs to know

21 Sep 2015 – From PCR London Valves 2015

Dr. Alec Vahanian

Chairperson

Alec Vahanian
Genco Yucel

Chairperson

Genco Yucel

LIVE demonstration: TAVI in a bicuspid aortic valve

20 Sep 2016 – From PCR London Valves 2016

Consult this session video if you want to learn more about TAVI in a bicuspid aortic valve, which includes a LIVE demonstration from Swiss Cardiovascular Centre, Bern University Hospital - Bern, Switzerland.

Clinical case

A 74-year-old male with bicuspid aortic stenosis:

Conscious sedationTransfemoral accessWith pre-dilatation
Prof. Jeroen J. Bax

Chairperson

Jeroen Bax
Dr. Alec Vahanian

Chairperson

Alec Vahanian

Expanding TAVI to lower-risk patients with bicuspid valve disease: optimising outcomes through imaging

20 Sep 2016 – From PCR London Valves 2016

Consult the session video on expanding TAVI to lower-risk patients with bicuspid valve disease and optimising outcomes through imaging.

Prof. Jeroen J. Bax

Chairperson

Jeroen Bax
Dr. Alec Vahanian

Chairperson

Alec Vahanian

Extending the indications for TAVI to patients with asymptomatic severe aortic stenosis

20 Sep 2016 – From PCR London Valves 2016

Dr. Martin B. Leon

Chairperson

Martin B. Leon

Chairperson

Philippe Pibarot

Long-term outcomes after TAVI

19 Sep 2016 – From PCR London Valves 2016

Prof. Ran Kornowski

Chairperson

Ran Kornowski
Helge Moellmann

Chairperson

Helge Moellmann

What is the known unknown about TAVI?

16 Sep 2013 – From PCR London Valves 2013

Prof. Alain Cribier

Chairperson

Alain Cribier

Chairperson

Neil Moat